Second Sight Medical (NSDQ:EYES) said yesterday that it plans to accelerate development and commercialization of its Orion visual cortical prosthesis system and posted first quarter earnings that missed expectations on Wall Street. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal […]
Glaukos posts Street-topping Q1 earnings
Glaukos (NYSE:GKOS) yesterday posted first quarter 2019 earnings that topped both loss per share and sales expectations on Wall Street. The San Clemente, Calif.-based company posted losses of $1.3 million, or 4¢ per share, on sales of approximately $54 million for the three months ended March 31, seeing losses shrink 50.5% while sales grew 34.6% when […]
Staar Surgical shares drop on FDA request for more data on EVO/EVO+ Visian lenses PMA bid
Staar Surgical (NSDQ:STAA) shares are down more than 10% after the company said it received a letter from the FDA’s Center for Devices and Radiological Health requesting more data for the premarket approval application supplement for its EVO/EVO+ Visian implantable collamer lenses for myopia and myopia with astigmatism. The federal watchdog said that the supplement lacked […]
Atia Vision raises $20m Series D
Atia Vision said today that it raised a $20 million Series D round for the intra-ocular lens it’s developing to treat far-sightedness. Campbell, Calif.-based Atia, which spun out of the Shifamed incubator there, said the round was led by Cormorant Asset Management and included the Capital Partnership, AMED Ventures and Shangbay Capital. Proceeds from the […]
Ocular Therapeutix settles Mati Therapeutics patent spat, logs CMS win for Dextenza
Ocular Therapeutix (NSDQ:OCUL) said this week it settled a patent spat with Mati Therapeutics and that it won reimbursement from the Centers for Medicare and Medicaid Services for its Dextenza ocular insert. In an SEC filing posted yesterday, the Bedford, Mass.-based company said that it settled its litigation with Mati Therapeutics and that both parties dismissed […]
Implandata wins CE Mark for Eyemate eye pressur sensor
Implandata Ophthalmic Products said today it won CE Mark approval in the European Union for its Eyemate system intended for use in patients undergoing keratoprosthetsis surgery. The Eyemate device is designed to allow ophthalmologists to detect increase intraocular pressure so they can better manage patients’ conditions to reduce the risk of post-surgical complications and vision […]
Glaukos, Santen ink U.S. MicroShunt distro deal
Glaukos (NYSE:GKOS) said last Friday that it inked a multi-year distribution deal with Santen Pharmaceutical (OTC:SNPHY) to market its MicroShunt device, intended to reduce intraocular pressure in patients with primary open-angle glaucoma (POAG), in the U.S. Through the deal, San Clemente, Calif.-based Glaukos will become the exclusive U.S. distributor of the MicroShunt, which is being studied in […]
Presbia abandons Flexivue microlens, lays off all but 3
Presbia (NSDQ:LENS) yesterday said it spiked its Flexivue microlens development program in the face of FDA headwinds, laying off all but three of its employees as it seeks investors to bail it out. Earlier this month the Irvine, Calif.-based company delayed the pre-market approval timeline for Flexivue, which is designed to treat far-sightedness or presbyopia, after […]
Glaukos touts 5-year study of glaucoma stents
Glaukos (NYSE:GKOS) said today that a study of its iStent trabecular micro-bypass stents reduced eye pressure in glaucoma patients five years after implant. The same study showed that significantly fewer iStent patients needed add-on medications after five years, the company said. The study showed that newly diagnosed, primary open-angle glaucoma (POAG) patients who received two […]
Second Sight Medical releases early feasibility data on Orion cortical implant
Second Sight Medical (NSDQ:EYES) today announced preliminary results from a small feasibility study of its Orion cortical implant, which is designed to give eyesight to the blind. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal and translates it to […]
Presbia delays Flexivue Microlens FDA PMA approval timeline again
Presbia (NSDQ:LENS) has delayed the timeline for approval of its Flexivue Microlens for treating far-sightedness again due to an earlier request for more information from the FDA. The Irvine, Calif.-based company was told last October that it had 180 days to provide the agency with 36-month data from all subjects enrolled in the staged pivotal clinical […]
- 1
- 2
- 3
- …
- 68
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube